Suppr超能文献

LRRK2 抑制可使 GBA1 突变星形细胞中的溶酶体和炎症缺陷恢复正常。

Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.

机构信息

Ann Romney Center for Neurological Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Department of Physiology, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Mov Disord. 2020 May;35(5):760-773. doi: 10.1002/mds.27994. Epub 2020 Feb 8.

Abstract

BACKGROUND

Autosomal recessive mutations in the glucocerebrosidase gene, Beta-glucocerebrosidase 1 (GBA1), cause the lysosomal storage disorder Gaucher's disease. Heterozygous carriers of most GBA1 mutations have dramatically increased Parkinson's disease (PD) risk, but the mechanisms and cells affected remain unknown. Glucocerebrosidase expression is relatively enriched in astrocytes, yet the impact of its mutation in these cells has not yet been addressed.

OBJECTIVES

Emerging data supporting non-cell-autonomous mechanisms driving PD pathogenesis inspired the first characterization of GBA1-mutant astrocytes. In addition, we asked whether LRRK2, likewise linked to PD and enriched in astrocytes, intersected with GBA1 phenotypes.

METHODS

Using heterozygous and homozygous GBA1 D409V knockin mouse astrocytes, we conducted rigorous biochemical and image-based analyses of lysosomal function and morphology. We also examined basal and evoked cytokine response at the transcriptional and secretory levels.

RESULTS

The D409V knockin astrocytes manifested broad deficits in lysosomal morphology and function, as expected. This, however, is the first study to show dramatic defects in basal and TLR4-dependent cytokine production. Albeit to different extents, both the lysosomal dysfunction and inflammatory responses were normalized by inhibition of LRRK2 kinase activity, suggesting functional intracellular crosstalk between glucocerebrosidase and LRRK2 activities in astrocytes.

CONCLUSIONS

These data demonstrate novel pathologic effects of a GBA1 mutation on inflammatory responses in astrocytes, indicating the likelihood of broader immunologic changes in GBA-PD patients. Our findings support the involvement of non-cell-autonomous mechanisms contributing to the pathogenesis of GBA1-linked PD and identify new opportunities to correct these changes with pharmacological intervention. © 2020 International Parkinson and Movement Disorder Society.

摘要

背景

葡糖脑苷脂酶基因(Beta-glucocerebrosidase 1,GBA1)的常染色体隐性突变导致溶酶体贮积病戈谢病。大多数 GBA1 突变的杂合携带者帕金森病(Parkinson's disease,PD)风险显著增加,但发病机制和受影响的细胞仍不清楚。葡糖脑苷脂酶的表达在星形胶质细胞中相对丰富,但尚未研究其在这些细胞中的突变的影响。

目的

支持非细胞自主机制驱动 PD 发病机制的新兴数据激发了对 GBA1 突变星形胶质细胞的首次特征描述。此外,我们还询问了同样与 PD 相关且在星形胶质细胞中富集的 LRRK2 是否与 GBA1 表型相交。

方法

我们使用杂合和纯合 GBA1 D409V 基因敲入小鼠星形胶质细胞,对溶酶体功能和形态进行了严格的生化和基于图像的分析。我们还检查了转录和分泌水平的基础和诱发细胞因子反应。

结果

正如预期的那样,D409V 基因敲入星形胶质细胞表现出广泛的溶酶体形态和功能缺陷。然而,这是第一项显示基础和 TLR4 依赖性细胞因子产生的显著缺陷的研究。尽管程度不同,但 LRRK2 激酶活性的抑制均可使溶酶体功能障碍和炎症反应正常化,这表明在星形胶质细胞中,葡萄糖脑苷脂酶和 LRRK2 活性之间存在功能性细胞内串扰。

结论

这些数据表明 GBA1 突变对星形胶质细胞炎症反应的新病理影响,表明 GBA-PD 患者中存在更广泛的免疫变化的可能性。我们的研究结果支持非细胞自主机制参与 GBA1 相关 PD 的发病机制,并确定了用药物干预纠正这些变化的新机会。国际帕金森病和运动障碍学会 2020 年。

相似文献

6
The relationship between glucocerebrosidase mutations and Parkinson disease.葡萄糖脑苷脂酶突变与帕金森病之间的关系。
J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10.

引用本文的文献

5
Immune cell metabolic dysfunction in Parkinson's disease.帕金森病中的免疫细胞代谢功能障碍
Mol Neurodegener. 2025 Mar 24;20(1):36. doi: 10.1186/s13024-025-00827-y.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验